Afimkibart | Clinical Trials Search

找到 15 条关于 “Afimkibart”

需要更精确的结果？

可按分期、招募状态、国家、申办方、年龄和研究类型筛选。

高级筛选临床试验

A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis

计划入组 100 人 · 首次发布于 2025 年 9 月 5 日

进行中（未招募）

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

计划入组 162 人 · 首次发布于 2025 年 3 月 7 日

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

计划入组 600 人 · 首次发布于 2025 年 2 月 11 日

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

计划入组 350 人 · 首次发布于 2024 年 9 月 19 日

进行中（未招募）

A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

计划入组 400 人 · 首次发布于 2024 年 9 月 19 日

进行中（未招募）

Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

计划入组 21 人 · 首次发布于 2023 年 6 月 18 日

An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis

计划入组 120 人 · 首次发布于 2026 年 6 月 2 日

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

计划入组 120 人 · 首次发布于 2025 年 11 月 3 日

A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease

计划入组 100 人 · 首次发布于 2025 年 12 月 23 日

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

计划入组 160 人 · 首次发布于 2025 年 8 月 22 日

第 1 页，共 2 页